About
Oskar joined BioGeneration as a partner in 2016 strengthening the team with his commercial, business development and consulting experience. Oskar started his career in McKinsey & Company as a management consultant. After that he held positions in Crucell first as business development director and later he became responsible for the Pediatric Franchise. After the acquisition of Crucell by Johnson & Johnson, Oskar led the Vaccines & Infectious Diseases business unit in Johnson & Johnson’s pharma joint venture Xian Janssen in Beijing, China. Prior to joining BioGeneration he was Chief Commercial Officer of Avantium, a leading chemical technology company and a forerunner in renewable chemistry. Oskar has a degree in chemical engineering from the Twente University (NL) and holds a MBA from INSEAD.
Position in the VCSift Database
- • 2 investors at BioGeneration Ventures are tracked.
- • 2,531 investors hold the Partner role in VCSift. Oskar Slotboom is one of them.
- • 6 investors are based in Naarden, Noord-Holland, The Netherlands.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Naarden, The Netherlands
Contact Information
Find more investors like Oskar
Search Investors